Prostate Cancer VL

Depressed Men with PCa are Less Likely to Undergo Definitive Therapy and Experience Worse OS

Details
Effect of Depression on Diagnosis, Treatment, and Mortality of Men with Clinically Localized Prostate Cancer Sandip M. Prasad, MD, MPhil Medical University of South Carolina RELATED CONTENT Click HERE to read the abstract Click HERE to watch a video blog from the editor-in-chief, Tom Keane, MD BIOGRAPHY Dr. Prasad received his undergraduate degree with highest honors from Harvard University, a Mas...

Multiparametric Prostate MRI and MRI/Ultrasound Fusion Biopsy

Details
Multiparametric Prostate MRI and MRI/Ultrasound Fusion Biopsy in the Follow-up of Prostate Cancer Progression for Men on Active Surveillance Annerleim Walton-Diaz, MD National Institutes of Health Click HERE to view the presenter's slides from this session Click HERE to read an exclusive report by a UroToday medical writer

Validation of 46-gene CCP RNA Signature for Predicting PCa Death

Details
Validation of a 46-gene Cell Cycle Progression (CCP) RNA Signature for Predicting Prostate Cancer Death Peter T. Scardino, MD, FACS Memorial Sloan Kettering Cancer Center Click HERE to read an exclusive report by a UroToday medical writer. Click HERE to view the poster from this session.

Validation of Genomic Classifier After Radical Prostatectomy

Details
AUA 2014 - Independent Validation of a Genomic Classifier in an at-risk Population of Men Conservatively Managed After Radical Prostatectomy Eric Klein, MD Cleveland Clinic

Predicting Radical Prostatectomy Outcome

Details
Predicting Radical Prostatectomy Outcome: CCP-CR Score Outperforms Primary Gleason Grade Among Men with Clinical Gleason less than 7 who are Upgraded to Gleason 7 Matthew R. Cooperberg, MD, MPH UCSF Medical Center Click HERE to view the poster from this session

Serum Testosterone on Continuous ADT: Is the Level Important?

Details
Serum Testosterone on Continuous ADT: Is the Level Important? Laurence Klotz, MD Click HERE to read an exclusive report by a UroToday medical writer Click HERE to view the poster from this session

Hormones & Radiation for High-Risk PCa+

Details
Hormones and Radiation for High-Risk PCa+ Anthony V. D'Amico, MD, PhD

Economic Impact of Training and Career Decisions in Urologic Surgery

Details
Economic Impact of Training and Career Decisions in Urologic Surgery Joshua Langston, MD

ADT with GnRH Antagonists

Details
Androgen Deprivation Therapy with GnRH Antagonists Thomas E. Keane, MD

Active Surveillance in PCa+

Details
Active Surveillance - Current Status and Future Directions Laurence Klotz, MD Sunnybrook Health Sciences Centre